Your browser doesn't support javascript.
loading
Switching from dupilumab to tralokinumab in patients with atopic dermatitis due to inefficacy or side effects.
Lasheras-Pérez, Miguel Antonio; Palacios-Diaz, Rodolfo David; Pozuelo-Ruiz, Monica; Torres-Navarro, Ignacio; Botella-Estrada, Rafael; Rodriguez-Serna, Mercedes.
Affiliation
  • Lasheras-Pérez MA; Department of Dermatology, La Fe University and Polytechnic Hospital, Valencia, Spain.
  • Palacios-Diaz RD; Department of Dermatology, La Fe University and Polytechnic Hospital, Valencia, Spain.
  • Pozuelo-Ruiz M; Department of Dermatology, La Fe University and Polytechnic Hospital, Valencia, Spain.
  • Torres-Navarro I; Department of Dermatology, La Fe University and Polytechnic Hospital, Valencia, Spain.
  • Botella-Estrada R; Department of Dermatology, La Fe University and Polytechnic Hospital, Valencia, Spain.
  • Rodriguez-Serna M; Department of Dermatology, University of Valencia, Valencia, Spain.
Int J Dermatol ; 63(1): 105-107, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38014601
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dermatitis, Atopic Limits: Humans Language: En Journal: Int J Dermatol Year: 2024 Document type: Article Affiliation country: Spain Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dermatitis, Atopic Limits: Humans Language: En Journal: Int J Dermatol Year: 2024 Document type: Article Affiliation country: Spain Country of publication: United kingdom